NIH Library of Medicine PubMed Central<\/p>\n\n\n\n
Journal List<\/a> Medicine (Baltimore)<\/a> v.95(40); 2016 Oct<\/a> PMC5059044<\/p>\n\n\n\n Background: In China, acupuncture has been proposed as a potential treatment for chronic obstructive pulmonary disease (COPD). However, the current evidence lacks sufficient support to firmly establish the effectiveness of acupuncture in COPD. Therefore, this multicenter, randomized, sham-controlled study was devised to assess the efficacy of acupuncture in treating patients with COPD.<\/p>\n\n\n\n Methods: This is a two-arm, parallel-group, multicenter, randomized, sham-controlled trial with concealed allocation, ensuring blinding of participants, assessors, and analysts. Seventy-two COPD participants were recruited and randomly assigned to two groups (real acupuncture group and sham acupuncture group) in a 1:1 ratio. Patients underwent either real or sham needling at identical acupoints three times weekly for 8 weeks. The primary outcome measured was dyspnea on exertion, evaluated using the 6-minute walk test. Additionally, health-related quality of life was assessed. Measurements were taken at baseline and after 8 weeks of treatment.<\/p>\n\n\n\n Results: Significant improvements in the six-minute walking distance and health-related quality of life were observed in the real acupuncture group compared to the sham acupuncture group.<\/p>\n\n\n\n Conclusion: The findings suggest that acupuncture can serve as an adjunctive therapy to alleviate dyspnea in patients with COPD.<\/p>\n\n\n\n \u80cc\u666f\uff1a \u5728\u4e2d\u570b\uff0c\u91dd\u7078\u88ab\u63d0\u8b70\u4f5c\u70ba\u6cbb\u7642\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\uff08COPD\uff09\u7684\u4e00\u7a2e\u53ef\u80fd\u65b9\u6cd5\u3002\u7136\u800c\uff0c\u76ee\u524d\u7684\u8b49\u64da\u4e0d\u8db3\u4ee5\u5f97\u51fa\u91dd\u5c0dCOPD\u4e2d\u91dd\u7078\u7642\u6548\u7684\u660e\u78ba\u7d50\u8ad6\u3002\u56e0\u6b64\uff0c\u8a2d\u8a08\u4e86\u9019\u9805\u591a\u4e2d\u5fc3\u3001\u96a8\u6a5f\u3001\u5047\u63a7\u5236\u7814\u7a76\uff0c\u65e8\u5728\u8a55\u4f30\u91dd\u7078\u6cbb\u7642COPD\u60a3\u8005\u7684\u6548\u679c\u3002<\/p>\n\n\n\n \u65b9\u6cd5\uff1a \u9019\u662f\u4e00\u9805\u96d9\u81c2\u3001\u5e73\u884c\u7d44\u3001\u591a\u4e2d\u5fc3\u3001\u96a8\u6a5f\u3001\u5047\u63a7\u5236\u7684\u8a66\u9a57\uff0c\u6709\u96b1\u85cf\u7684\u5206\u914d\uff0c\u78ba\u4fdd\u4e86\u53c3\u8207\u8005\u3001\u8a55\u4f30\u8005\u548c\u5206\u6790\u8005\u7684\u76f2\u6cd5\u3002\u5171\u62db\u52df\u4e8672\u540dCOPD\u60a3\u8005\uff0c\u4e26\u63091:1\u6bd4\u4f8b\u96a8\u6a5f\u5206\u70ba2\u7d44\uff08\u771f\u91dd\u7078\u7d44\u548c\u5047\u91dd\u7078\u7d44\uff09\u3002\u60a3\u8005\u6bcf\u9031\u63a5\u53d7\u76f8\u540c\u7a74\u4f4d\u7684\u771f\u91dd\u7078\u6216\u5047\u91dd\u70783\u6b21\uff0c\u70ba\u671f8\u9031\u3002\u4e3b\u8981\u7d50\u679c\u662f\u4f7f\u75286\u5206\u9418\u6b65\u884c\u6e2c\u8a66\u8a55\u4f30\u7684\u904b\u52d5\u6027\u547c\u5438\u56f0\u96e3\u3002\u6b64\u5916\uff0c\u9084\u8a55\u4f30\u4e86\u5065\u5eb7\u76f8\u95dc\u751f\u6d3b\u8cea\u91cf\u3002\u6e2c\u91cf\u5728\u57fa\u7dda\u548c\u6cbb\u7642\u5f8c8\u9031\u9032\u884c\u3002<\/p>\n\n\n\n \u7d50\u679c\uff1a \u771f\u91dd\u7078\u7d44\u7684\u516d\u5206\u9418\u6b65\u884c\u8ddd\u96e2\u548c\u5065\u5eb7\u76f8\u95dc\u751f\u6d3b\u8cea\u91cf\u660e\u986f\u512a\u65bc\u5047\u91dd\u7078\u7d44\u3002<\/p>\n\n\n\n \u7d50\u8ad6\uff1a \u7814\u7a76\u7d50\u679c\u8868\u660e\uff0c\u91dd\u7078\u53ef\u4f5c\u70ba\u8f14\u52a9\u7642\u6cd5\uff0c\u6e1b\u8f15COPD\u60a3\u8005\u7684\u904b\u52d5\u6027\u547c\u5438\u56f0\u96e3\u3002<\/p>\n\n\n\n Link to original article:<\/p>\n\n\n\n